Could The Market Be Wrong About Cochlear Limited (ASX:COH) Given Its Attractive Financial Prospects?
It is hard to get excited after looking at Cochlear's (ASX:COH) recent performance, when its stock has declined 7.6% over the past three months. However, a closer look at its sound financials might ...
Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...
LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to ...
Cochlear Limited, a medical device company specializing in implantable hearing solutions, is launching two new bone conduction sound processor devices for patients with high levels of hearing loss.
Investors continue to question valuation and wait for stronger earnings momentum. The post Cochlear shares lag the ASX 200 ...
LONE TREE, Colo., May 3, 2021 /PRNewswire/ -- Adults with cochlear implants may be able to improve their listening and communications skills in daily life with the help of a new self-guided digital ...
In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Cochlear Limited (CHEOF – Research Report), with a price target of A$240.00. The company’s shares closed ...
Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
Cochlear Limited (AU:COH) has released an update. Cochlear Limited recently reported changes in the interests of its director, Diggory William Howitt, involving the acquisition of 11,000 shares and ...
Cochlear Limited (AU:COH) has released an update. Cochlear Limited has announced the results of its 2024 Annual General Meeting, with all resolutions carried by significant majorities. The company’s ...
MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology, which specializes in the development of novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback